Following oral administration of WA five days/week for four weeks, an analysis of the tumor volumes revealed that WA treatment significantly inhibited the growth of both pCMV/HCT-116- and AKT/HCT-116-induced CRC tumors, without causing significant toxicity to the animals (Figure 7A). Here, AKT1 is linked to neoplasm.